Page of

Conclusion

Conclusion

The Social Inequality of Adverse Events

Chapter:
(p.253) Conclusion
Source:
Adverse Events
Author(s):
Jill A. Fisher
Publisher:
NYU Press
DOI:10.18574/nyu/9781479877997.003.0011

The book’s conclusion reflects on the political and economic context of US Phase I trials. A society characterized by deeply imbricated stigmas ensures that there will always be healthy volunteers willing to enroll in Phase I trials, whether these are the same or new participants who need the financial compensation. Ultimately, attending to the underlying social inequalities animating the Phase I industry is critical to understand what is at stake when healthy volunteers are used in drug development.

Keywords:   Phase I trials, healthy volunteers, social inequalities, imbricated stigma, United States, drug development, pharmaceutical industry

Sign In

Copyright © 2021. All rights reserved.
Privacy Policy and Legal Notice